1 min read
Nasus Pharma Names Nir Sassi Chief Financial Officer Effective Nov. 11
Sassi most recently served as CFO of Indaptus Therapeutics and previously held the role at Intec Pharma.

Nasus Pharma Ltd. appointed Nir Sassi as chief financial officer effective Nov. 11, the company announced Monday. Its shares trade on the New York Stock Exchange under the ticker NSRX.
Sassi most recently served as CFO of Indaptus Therapeutics. He previously held the same role at Intec Pharma.